Low‐dose gemcitabine plus nab‐paclitaxel versus standard‐dose gemcitabine plus nab‐paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial.
- Resource Type
- Article
- Source
- JGH Open; Sep2023, Vol. 7 Issue 9, p659-666, 8p
- Subject
OLDER patients PANCREATIC cancer METASTASIS GEMCITABINE ADVERSE health care events - Language
- ISSN
- 23979070